Clinical Applications of Metronomic Chemotherapy

• Andere auteurs: Bocci, Guido (Redacteur), Francia, Giulio (Redacteur)
• Formaat: Elektronisch Hoofdstuk
• Taal: Engels
• Gepubliceerd in: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
• Onderwerpen: Medicine; metronomic; oral cancer; oral squamous cell carcinoma; metronomic chemotherapy; metastatic castration-resistant prostate cancer; cyclophosphamide; side effects; pediatric tumors; etoposide; valproic acid; prostate cancer; CRPC; castration; capecitabine; paclitaxel; immunomodulation; angiogenesis; microbiome; breast cancer; safety; preclinical studies; clinical studies; pharmacokinetic studies; biomarkers; chemo-free; DLBCL; diffuse-large-b-cell-lymphoma; elderly; frail; comprehensive geriatric assessment; chemo-endocrine therapy; FulVEC; pediatric oncology; brain tumors; pharmacology; medulloblastoma; ATRT; immunotherapy; lymphoma; vinorelbine; checkpoint inhibitors
• Online toegang: DOAB: download the publication; DOAB: description of the publication

Metronomic chemotherapy is now, finally, in clinical use. After 20 years of preclinical development and clinical trials, the emerging data will be of paramount importance in allowing us to assess the impact of metronomic chemotherapy on different tumor types. Indeed, it is likely that the next decad...